Prostaglandins and sickness behavior: Old story, new insights

Physiology and Behavior

Volumn 97, Issue 3-4, 2009, Pages 279-292

  Pecchi, Emilie ^a   Dallaporta, Michel ^a   Jean, André ^a   Thirion, Sylvie ^a   Troadec, Jean Denis ^a  

^a University of Mediterranée   (France)

Author keywords

Anorexia; Cyclooxygenase; Fever; Prostaglandin; Prostaglandin E synthase; Sickness behavior

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; PROSTANOID;

ANOREXIA; BRAIN FUNCTION; BRAIN REGION; DEPRESSION; DISEASE COURSE; ENCEPHALITIS; FEVER; HUMAN; HUMORAL IMMUNITY; ILLNESS BEHAVIOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; UPREGULATION; VAGUS NERVE STIMULATION;

ANIMALS; BRAIN; HUMANS; ILLNESS BEHAVIOR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS;

EID: 67349219641     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2009.02.040     Document Type: Review

References (196)

1. Hart B.L. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12 (1988) 123-137
2. Kluger M.J. Is fever beneficial?. Yale J Biol Med 59 (1986) 89-95
3. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 500 (2004) 399-411
4. Murray M.J., and Murray A.B. Anorexia of infection as a mechanism of host defense. Am J Clin Nutr 32 (1979) 593-596
5. Tisdale M.J. Cachexia in cancer patients. Nat Rev Cancer 2 (2002) 862-871
6. Anderson K.V. Toll signaling pathways in the innate immune response. Curr Opin Immunol 12 (2000) 13-19
7. Dunne A., and O'Neill L.A. The interleukin-1 receptor/toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE (2003) 2003:re3
8. Kelley K.W., Bluthe R.M., Dantzer R., Zhou J.H., Shen W.H., Johnson R.W., et al. Cytokine-induced sickness behavior. Brain Behav Immun 17 Suppl 1 (2003) S112-118
9. Long N.C., Otterness I., Kunkel S.L., Vander A.J., and Kluger M.J. Roles of interleukin 1 beta and tumor necrosis factor in lipopolysaccharide fever in rats. Am J Physiol 259 (1990) R724-728
10. Bluthe R.M., Dantzer R., and Kelley K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res 573 (1992) 318-320
11. Kozak W., Zheng H., Conn C.A., Soszynski D., van der Ploeg L.H., and Kluger M.J. Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1 beta-deficient mice. Am J Physiol 269 (1995) R969-977
12. Luheshi G., Miller A.J., Brouwer S., Dascombe M.J., Rothwell N.J., and Hopkins S.J. Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am J Physiol 270 (1996) E91-95
13. Swiergiel A.H., Smagin G.N., Johnson L.J., and Dunn A.J. The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Brain Res 776 (1997) 96-104
14. Kozak W., Kluger M.J., Soszynski D., Conn C.A., Rudolph K., Leon L.R., et al. IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice. Ann N Y Acad Sci 856 (1998) 33-47
15. Yao J.H., Ye S.M., Burgess W., Zachary J.F., Kelley K.W., and Johnson R.W. Mice deficient in interleukin-1beta converting enzyme resist anorexia induced by central lipopolysaccharide. Am J Physiol 277 (1999) R1435-1443
16. Laye S., Gheusi G., Cremona S., Combe C., Kelley K., Dantzer R., et al. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am J Physiol Regul Integr Comp Physiol 279 (2000) R93-98
17. Laviano A., Renvyle T., Meguid M.M., Yang Z.J., Cangiano C., and Rossi Fanelli F. Relationship between interleukin-1 and cancer anorexia. Nutrition 11 (1995) 680-683
18. El-Haj T., Poole S., Farthing M.J., and Ballinger A.B. Anorexia in a rat model of colitis: interaction of interleukin-1 and hypothalamic serotonin. Brain Res 927 (2002) 1-7
19. Fantuzzi G., Zheng H., Faggioni R., Benigni F., Ghezzi P., Sipe J.D., et al. Effect of endotoxin in IL-1 beta-deficient mice. J Immunol 157 (1996) 291-296
20. Alheim K., Chai Z., Fantuzzi G., Hasanvan H., Malinowsky D., Di Santo E., et al. Hyperresponsive febrile reactions to interleukin (IL) 1alpha and IL-1beta, and altered brain cytokine mRNA and serum cytokine levels, in IL-1beta-deficient mice. Proc Natl Acad Sci U S A 94 (1997) 2681-2686
21. Bluthe R.M., Laye S., Michaud B., Combe C., Dantzer R., and Parnet P. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. Eur J Neurosci 12 (2000) 4447-4456
22. Plata-Salaman C.R., Oomura Y., and Kai Y. Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system. Brain Res 448 (1988) 106-114
23. LeMay L.G., Vander A.J., and Kluger M.J. Role of interleukin 6 in fever in rats. Am J Physiol 258 (1990) R798-803
24. Fantino M., and Wieteska L. Evidence for a direct central anorectic effect of tumor-necrosis-factor-alpha in the rat. Physiol Behav 53 (1993) 477-483
25. Klir J.J., Roth J., Szelenyi Z., McClellan J.L., and Kluger M.J. Role of hypothalamic interleukin-6 and tumor necrosis factor-alpha in LPS fever in rat. Am J Physiol 265 (1993) R512-517
26. Schobitz B., Pezeshki G., Pohl T., Hemmann U., Heinrich P.C., Holsboer F., et al. Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. Faseb J 9 (1995) 659-664
27. Chai Z., Gatti S., Toniatti C., Poli V., and Bartfai T. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice. J Exp Med 183 (1996) 311-316
28. Rummel C., Sachot C., Poole S., and Luheshi G.N. Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain. Am J Physiol Regul Integr Comp Physiol 291 (2006) R1316-1326
29. Leon L.R., Kozak W., Peschon J., and Kluger M.J. Exacerbated febrile responses to LPS, but not turpentine, in TNF double receptor-knockout mice. Am J Physiol 272 (1997) R563-569
30. Swiergiel A.H., and Dunn A.J. Feeding, exploratory, anxiety- and depression-related behaviors are not altered in interleukin-6-deficient male mice. Behav Brain Res 171 (2006) 94-108
31. Sharma R.J., Macallan D.C., Sedgwick P., Remick D.G., and Griffin G.E. Kinetics of endotoxin-induced acute-phase protein gene expression and its modulation by TNF-alpha monoclonal antibody. Am J Physiol 262 (1992) R786-793
32. Swiergiel A.H., and Dunn A.J. The roles of IL-1, IL-6, and TNFalpha in the feeding responses to endotoxin and influenza virus infection in mice. Brain Behav Immun 13 (1999) 252-265
33. Porter M.H., Hrupka B.J., Altreuther G., Arnold M., and Langhans W. Inhibition of TNF-alpha production contributes to the attenuation of LPS-induced hypophagia by pentoxifylline. Am J Physiol Regul Integr Comp Physiol 279 (2000) R2113-2120
34. Sherry B.A., Gelin J., Fong Y., Marano M., Wei H., Cerami A., et al. Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. Faseb J 3 (1989) 1956-1962
35. Smith B.K., and Kluger M.J. Anti-TNF-alpha antibodies normalized body temperature and enhanced food intake in tumor-bearing rats. Am J Physiol 265 (1993) R615-619
36. Molotkov A., Satoh M., and Tohyama C. Tumor growth and food intake in interleukin-6 gene knock-out mice. Cancer Lett 132 (1998) 187-192
37. Torelli G.F., Meguid M.M., Moldawer L.L., Edwards III C.K., Kim H.J., Carter J.L., et al. Use of recombinant human soluble TNF receptor in anorectic tumor-bearing rats. Am J Physiol 277 (1999) R850-855
38. Cahlin C., Korner A., Axelsson H., Wang W., Lundholm K., and Svanberg E. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia. Cancer Res 60 (2000) 5488-5493
39. Negri D.R., Mezzanzanica D., Sacco S., Gadina M., Benigni F., Cajola L., et al. Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours. Cytokine 15 (2001) 27-38
40. Gatti S., and Bartfai T. Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res 624 (1993) 291-294
41. Vallieres L., and Rivest S. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta. J Neurochem 69 (1997) 1668-1683
42. Kakizaki Y., Watanobe H., Kohsaka A., and Suda T. Temporal profiles of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in the plasma and hypothalamic paraventricular nucleus after intravenous or intraperitoneal administration of lipopolysaccharide in the rat: estimation by push-pull perfusion. Endocr J 46 (1999) 487-496
43. Churchill L., Taishi P., Wang M., Brandt J., Cearley C., Rehman A., et al. Brain distribution of cytokine mRNA induced by systemic administration of interleukin-1beta or tumor necrosis factor alpha. Brain Res 1120 (2006) 64-73
44. Sagar S.M., Price K.J., Kasting N.W., and Sharp F.R. Anatomic patterns of Fos immunostaining in rat brain following systemic endotoxin administration. Brain Res Bull 36 (1995) 381-392
45. Lacroix S., and Rivest S. Functional circuitry in the brain of immune-challenged rats: partial involvement of prostaglandins. J Comp Neurol 387 (1997) 307-324
46. Herkenham M., Lee H.Y., and Baker R.A. Temporal and spatial patterns of c-fos mRNA induced by intravenous interleukin-1: a cascade of non-neuronal cellular activation at the blood-brain barrier. J Comp Neurol 400 (1998) 175-196
47. Konsman J.P., Kelley K., and Dantzer R. Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain. Neuroscience 89 (1999) 535-548
48. Nadeau S., and Rivest S. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 93 (1999) 1449-1464
49. Marvel F.A., Chen C.C., Badr N., Gaykema R.P., and Goehler L.E. Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei. Brain Behav Immun 18 (2004) 123-134
50. Goehler L.E., Gaykema R.P., Nguyen K.T., Lee J.E., Tilders F.J., Maier S.F., et al. Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems?. J Neurosci 19 (1999) 2799-2806
51. Ek M., Kurosawa M., Lundeberg T., and Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci 18 (1998) 9471-9479
52. Goehler L.E., Gaykema R.P., Hammack S.E., Maier S.F., and Watkins L.R. Interleukin-1 induces c-Fos immunoreactivity in primary afferent neurons of the vagus nerve. Brain Res 804 (1998) 306-310
53. Niijima A. The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat. J Auton Nerv Syst 61 (1996) 287-291
54. Mascarucci P., Perego C., Terrazzino S., and De Simoni M.G. Glutamate release in the nucleus tractus solitarius induced by peripheral lipopolysaccharide and interleukin-1 beta. Neuroscience 86 (1998) 1285-1290
55. Laye S., Bluthe R.M., Kent S., Combe C., Medina C., Parnet P., et al. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am J Physiol 268 (1995) R1327-1331
56. Hansen M.K., Taishi P., Chen Z., and Krueger J.M. Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1beta. J Neurosci 18 (1998) 2247-2253
57. Gaykema R.P., Dijkstra I., and Tilders F.J. Subdiaphragmatic vagotomy suppresses endotoxin-induced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology 136 (1995) 4717-4720
58. Konsman J.P., Luheshi G.N., Bluthe R.M., and Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur J Neurosci 12 (2000) 4434-4446
59. Ge X., Yang Z., Duan L., and Rao Z. Evidence for involvement of the neural pathway containing the peripheral vagus nerve, medullary visceral zone and central amygdaloid nucleus in neuroimmunomodulation. Brain Res 914 (2001) 149-158
60. Sehic E., and Blatteis C.M. Blockade of lipopolysaccharide-induced fever by subdiaphragmatic vagotomy in guinea pigs. Brain Res 726 (1996) 160-166
61. Hansen M.K., O'Connor K.A., Goehler L.E., Watkins L.R., and Maier S.F. The contribution of the vagus nerve in interleukin-1beta-induced fever is dependent on dose. Am J Physiol Regul Integr Comp Physiol 280 (2001) R929-934
62. Bret-Dibat J.L., Bluthe R.M., Kent S., Kelley K.W., and Dantzer R. Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain Behav Immun 9 (1995) 242-246
63. Luheshi G.N., Bluthe R.M., Rushforth D., Mulcahy N., Konsman J.P., Goldbach M., et al. Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats. Auton Neurosci 85 (2000) 127-132
64. Hansen M.K., Daniels S., Goehler L.E., Gaykema R.P., Maier S.F., and Watkins L.R. Subdiaphragmatic vagotomy does not block intraperitoneal lipopolysaccharide-induced fever. Auton Neurosci 85 (2000) 83-87
65. Romanovsky A.A., Simons C.T., Szekely M., and Kulchitsky V.A. The vagus nerve in the thermoregulatory response to systemic inflammation. Am J Physiol 273 (1997) R407-413
66. Goldbach J.M., Roth J., and Zeisberger E. Fever suppression by subdiaphragmatic vagotomy in guinea pigs depends on the route of pyrogen administration. Am J Physiol 272 (1997) R675-681
67. Plata-Salaman C.R., and Ilyin S.E. Interleukin-1beta (IL-1beta)-induced modulation of the hypothalamic IL-1beta system, tumor necrosis factor-alpha, and transforming growth factor-beta1 mRNAs in obese (fa/fa) and lean (Fa/Fa) Zucker rats: implications to IL-1beta feedback systems and cytokine-cytokine interactions. J Neurosci Res 49 (1997) 541-550
68. Niimi M., Sato M., Wada Y., Takahara J., and Kawanishi K. Effect of central and continuous intravenous injection of interleukin-1 beta on brain c-fos expression in the rat: involvement of prostaglandins. Neuroimmunomodulation 3 (1996) 87-92
69. Konsman J.P., Vigues S., Mackerlova L., Bristow A., and Blomqvist A. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J Comp Neurol 472 (2004) 113-129
70. Laflamme N., and Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J Neurochem 73 (1999) 309-321
71. Nadjar A., Combe C., Laye S., Tridon V., Dantzer R., Amedee T., et al. Nuclear factor kappaB nuclear translocation as a crucial marker of brain response to interleukin-1. A study in rat and interleukin-1 type I deficient mouse. J Neurochem 87 (2003) 1024-1036
72. Konsman J.P., Tridon V., and Dantzer R. Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS. Neuroscience 101 (2000) 957-967
73. Blatteis C.M., Bealer S.L., Hunter W.S., Llanos Q.J., Ahokas R.A., and Mashburn Jr. T.A. Suppression of fever after lesions of the anteroventral third ventricle in guinea pigs. Brain Res Bull 11 (1983) 519-526
74. Hashimoto M., Ueno T., and Iriki M. What roles does the organum vasculosum laminae terminalis play in fever in rabbits?. Pflugers Arch 429 (1994) 50-57
75. Ching S., Zhang H., Belevych N., He L., Lai W., Pu X.A., et al. Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration. J Neurosci 27 (2007) 10476-10486
76. Ilyin S.E., Gayle D., Flynn M.C., and Plata-Salaman C.R. Interleukin-1beta system (ligand, receptor type I, receptor accessory protein and receptor antagonist), TNF-alpha, TGF-beta1 and neuropeptide Y mRNAs in specific brain regions during bacterial LPS-induced anorexia. Brain Res Bull 45 (1998) 507-515
77. Wan W., Janz L., Vriend C.Y., Sorensen C.M., Greenberg A.H., and Nance D.M. Differential induction of c-Fos immunoreactivity in hypothalamus and brain stem nuclei following central and peripheral administration of endotoxin. Brain Res Bull 32 (1993) 581-587
78. Johnson R.W., Gheusi G., Segreti S., Dantzer R., and Kelley K.W. C3H/HeJ mice are refractory to lipopolysaccharide in the brain. Brain Res 752 (1997) 219-226
79. Nadeau S., and Rivest S. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor kappa B activity in the brain during endotoxemia. J Neurosci 20 (2000) 3456-3468
80. Laflamme N., and Rivest S. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. Faseb J 15 (2001) 155-163
81. Chakravarty S., and Herkenham M. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J Neurosci 25 (2005) 1788-1796
82. Wisse B.E., Ogimoto K., Tang J., Harris Jr. M.K., Raines E.W., and Schwartz M.W. Evidence that lipopolysaccharide-induced anorexia depends upon central, rather than peripheral, inflammatory signals. Endocrinology 148 (2007) 5230-5237
83. French R.A., VanHoy R.W., Chizzonite R., Zachary J.F., Dantzer R., Parnet P., et al. Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice. J Neuroimmunol 93 (1999) 194-202
84. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
85. Murakami M., and Kudo I. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res 43 (2004) 3-35
86. Ivanov A.I., Pero R.S., Scheck A.C., and Romanovsky A.A. Prostaglandin E(2)-synthesizing enzymes in fever: differential transcriptional regulation. Am J Physiol Regul Integr Comp Physiol 283 (2002) R1104-1117
87. Sirko S., Bishai I., and Coceani F. Prostaglandin formation in the hypothalamus in vivo: effect of pyrogens. Am J Physiol 256 (1989) R616-624
88. Sehic E., Szekely M., Ungar A.L., Oladehin A., and Blatteis C.M. Hypothalamic prostaglandin E2 during lipopolysaccharide-induced fever in guinea pigs. Brain Res Bull 39 (1996) 391-399
89. Engblom D., Saha S., Engstrom L., Westman M., Audoly L.P., Jakobsson P.J., et al. Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat Neurosci 6 (2003) 1137-1138
90. Grill M., Peskar B.A., Schuligoi R., and Amann R. Systemic inflammation induces COX-2 mediated prostaglandin D2 biosynthesis in mice spinal cord. Neuropharmacology 50 (2006) 165-173
91. Steiner A.A., Ivanov A.I., Serrats J., Hosokawa H., Phayre A.N., Robbins J.R., et al. Cellular and molecular bases of the initiation of fever. PLoS Biol (2006) e284
92. Vellucci S.V., and Parrott R.F. Hyperthermia-associated changes in Fos protein in the median preoptic and other hypothalamic nuclei of the pig following intravenous administration of prostaglandin E2. Brain Res 646 (1994) 165-169
93. Kandasamy S.B., and Williams B.A. Prostacyclin-induced hyperthermia: implication of a protein mediator. Neuropharmacology 21 (1982) 1065-1072
94. Forstermann U., Heldt R., and Hertting G. Effects of intracerebroventricular administration of prostaglandin D2 on behaviour, blood pressure and body temperature as compared to prostaglandins E2 and F2 alpha. Psychopharmacology (Berl) 80 (1983) 365-370
95. Splawinski J.A., Gorka Z., Zacny E., and Wojtaszek B. Hyperthermic effects of arachidonic acid, prostaglandin E2 and F2alpha in rats. Pflugers Arch 374 (1978) 15-21
96. Morimoto A., Murakami N., Nakamori T., and Watanabe T. Multiple control of fever production in the central nervous system of rabbits. J Physiol 397 (1988) 269-280
97. Doggett N.S., and Jawaharlal K. Anorectic activity of prostaglandin precursors. Br J Pharmacol 60 (1977) 417-423
98. Levine A.S., and Morley J.E. The effect of prostaglandins (PGE2 and PGF2 alpha) on food intake in rats. Pharmacol Biochem Behav 15 (1981) 735-738
99. Lal J. Possible role of prostaglandins in the regulation of food intake in the newborn rat. Arch Int Pharmacodyn Ther 272 (1984) 140-149
100. Lacroix S., Vallieres L., and Rivest S. C-fos mRNA pattern and corticotropin-releasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type. J Neuroimmunol 70 (1996) 163-179
101. Scammell T.E., Elmquist J.K., Griffin J.D., and Saper C.B. Ventromedial preoptic prostaglandin E2 activates fever-producing autonomic pathways. J Neurosci 16 (1996) 6246-6254
102. Zhang J., and Rivest S. Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur J Neurosci 11 (1999) 2651-2668
103. Oka T., Oka K., Scammell T.E., Lee C., Kelly J.F., Nantel F., et al. Relationship of EP(1-4) prostaglandin receptors with rat hypothalamic cell groups involved in lipopolysaccharide fever responses. J Comp Neurol 428 (2000) 20-32
104. Ek M., Arias C., Sawchenko P., and Ericsson-Dahlstrand A. Distribution of the EP3 prostaglandin E(2) receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness. J Comp Neurol 428 (2000) 5-20
105. Engblom D., Ek M., Ericsson-Dahlstrand A., and Blomqvist A. Activation of prostanoid EP(3) and EP(4) receptor mRNA-expressing neurons in the rat parabrachial nucleus by intravenous injection of bacterial wall lipopolysaccharide. J Comp Neurol 440 (2001) 378-386
106. Nakamura K., Kaneko T., Yamashita Y., Hasegawa H., Katoh H., and Negishi M. Immunohistochemical localization of prostaglandin EP3 receptor in the rat nervous system. J Comp Neurol 421 (2000) 543-569
107. Zhang J., and Rivest S. A functional analysis of EP4 receptor-expressing neurons in mediating the action of prostaglandin E2 within specific nuclei of the brain in response to circulating interleukin-1beta. J Neurochem 74 (2000) 2134-2145
108. Nakamura K., Li Y.Q., Kaneko T., Katoh H., and Negishi M. Prostaglandin EP3 receptor protein in serotonin and catecholamine cell groups: a double immunofluorescence study in the rat brain. Neuroscience 103 (2001) 763-775
109. Ushikubi F., Segi E., Sugimoto Y., Murata T., Matsuoka T., Kobayashi T., et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395 (1998) 281-284
110. Chandrasekharan N.V., Dai H., Roos K.L., Evanson N.K., Tomsik J., Elton T.S., et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A 99 (2002) 13926-13931
111. Hersh E.V., Lally E.T., and Moore P.A. Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?. Curr Med Res Opin 21 (2005) 1217-1226
112. Gierse J.K., McDonald J.J., Hauser S.D., Rangwala S.H., Koboldt C.M., and Seibert K. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. J Biol Chem 271 (1996) 15810-15814
113. Breder C.D., Dewitt D., and Kraig R.P. Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol 355 (1995) 296-315
114. Cao C., Matsumura K., Yamagata K., and Watanabe Y. Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain. Am J Physiol 272 (1997) R1712-1725
115. Lacroix S., and Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J Neurochem 70 (1998) 452-466
116. Ek M., Engblom D., Saha S., Blomqvist A., Jakobsson P.J., and Ericsson-Dahlstrand A. Inflammatory response: pathway across the blood-brain barrier. Nature 410 (2001) 430-431
117. Cao C., Matsumura K., Yamagata K., and Watanabe Y. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: a possible site of prostaglandin synthesis responsible for fever. Brain Res 733 (1996) 263-272
118. Matsumura K., Cao C., Ozaki M., Morii H., Nakadate K., and Watanabe Y. Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: light and electron microscopic immunocytochemical studies. J Neurosci 18 (1998) 6279-6289
119. Laflamme N., Lacroix S., and Rivest S. An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J Neurosci 19 (1999) 10923-10930
120. Elmquist J.K., Breder C.D., Sherin J.E., Scammell T.E., Hickey W.F., Dewitt D., et al. Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages. J Comp Neurol 381 (1997) 119-129
121. Schiltz J.C., and Sawchenko P.E. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J Neurosci 22 (2002) 5606-5618
122. Zhang Y.H., Lu J., Elmquist J.K., and Saper C.B. Specific roles of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain. J Comp Neurol 463 (2003) 3-12
123. Nadjar A., Bluthe R.M., May M.J., Dantzer R., and Parnet P. Inactivation of the cerebral NFkappaB pathway inhibits interleukin-1beta-induced sickness behavior and c-Fos expression in various brain nuclei. Neuropsychopharmacology 30 (2005) 1492-1499
124. Johnson R.W., Curtis S.E., Dantzer R., and Kelley K.W. Central and peripheral prostaglandins are involved in sickness behavior in birds. Physiol Behav 53 (1993) 127-131
125. Scammell T.E., Griffin J.D., Elmquist J.K., and Saper C.B. Microinjection of a cyclooxygenase inhibitor into the anteroventral preoptic region attenuates LPS fever. Am J Physiol 274 (1998) R783-789
126. Cao C., Matsumura K., Ozaki M., and Watanabe Y. Lipopolysaccharide injected into the cerebral ventricle evokes fever through induction of cyclooxygenase-2 in brain endothelial cells. J Neurosci 19 (1999) 716-725
127. Li S., Ballou L.R., Morham S.G., and Blatteis C.M. Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. Brain Res 910 (2001) 163-173
128. Langhans W., Harlacher R., and Scharrer E. Verapamil and indomethacin attenuate endotoxin-induced anorexia. Physiol Behav 46 (1989) 535-539
129. Shimomura Y., Inukai T., Kuwabara S., Shimizu H., Takahashi M., Sato N., et al. Both cyclooxygenase and lipoxygenase inhibitor partially restore the anorexia by interleukin-1 beta. Life Sci 51 (1992) 1419-1426
130. Swiergiel A.H., Smagin G.N., and Dunn A.J. Influenza virus infection of mice induces anorexia: comparison with endotoxin and interleukin-1 and the effects of indomethacin. Pharmacol Biochem Behav 57 (1997) 389-396
131. Lugarini F., Hrupka B.J., Schwartz G.J., Plata-Salaman C.R., and Langhans W. A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats. Am J Physiol Regul Integr Comp Physiol 283 (2002) R862-868
132. Johnson P.M., Vogt S.K., Burney M.W., and Muglia L.J. COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production. Am J Physiol Endocrinol Metab 282 (2002) E650-656
133. Swiergiel A.H., and Dunn A.J. Cyclooxygenase 1 is not essential for hypophagic responses to interleukin-1 and endotoxin in mice. Pharmacol Biochem Behav 69 (2001) 659-663
134. Swiergiel A.H., and Dunn A.J. Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes. J Pharmacol Exp Ther 302 (2002) 1031-1036
135. Dunn A.J., and Swiergiel A.H. The role of cyclooxygenases in endotoxin- and interleukin-1-induced hypophagia. Brain Behav Immun 14 (2000) 141-152
136. McMillan D.C., Wigmore S.J., Fearon K.C., O'Gorman P., Wright C.E., and McArdle C.S. A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer 79 (1999) 495-500
137. Lundholm K., Daneryd P., Korner U., Hyltander A., and Bosaeus I. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia. Int J Oncol 24 (2004) 505-512
138. Cahlin C., Gelin J., Delbro D., Lonnroth C., Doi C., and Lundholm K. Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids. Cancer Res 60 (2000) 1742-1749
139. Davis T.W., Zweifel B.S., O'Neal J.M., Heuvelman D.M., Abegg A.L., Hendrich T.O., et al. Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting. J Pharmacol Exp Ther 308 (2004) 929-934
140. Wang W., Andersson M., Lonnroth C., Svanberg E., and Lundholm K. Anorexia and cachexia in prostaglandin EP1 and EP3 subtype receptor knockout mice bearing a tumor with high intrinsic PGE2 production and prostaglandin related cachexia. J Exp Clin Cancer Res 24 (2005) 99-107
141. Wang W., Andersson M., Lonnroth C., Svanberg E., and Lundholm K. Prostaglandin E and prostacyclin receptor expression in tumor and host tissues from MCG 101-bearing mice: a model with prostanoid-related cachexia. Int J Cancer 115 (2005) 582-590
142. Crestani F., Seguy F., and Dantzer R. Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res 542 (1991) 330-335
143. Bluthe R.M., Crestani F., Kelley K.W., and Dantzer R. Mechanisms of the behavioral effects of interleukin 1. Role of prostaglandins and CRF. Ann N Y Acad Sci 650 (1992) 268-275
144. Avitsur R., Weidenfeld J., and Yirmiya R. Cytokines inhibit sexual behavior in female rats: II. Prostaglandins mediate the suppressive effects of interleukin-1beta. Brain Behav Immun 13 (1999) 33-45
145. Jain N.K., Kulkarni S.K., and Singh A. Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors. Methods Find Exp Clin Pharmacol 23 (2001) 441-444
146. Hayley S., Mangano E., Strickland M., and Anisman H. Lipopolysaccharide and a social stressor influence behaviour, corticosterone and cytokine levels: divergent actions in cyclooxygenase-2 deficient mice and wild type controls. J Neuroimmunol 197 (2008) 29-36
147. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231 (1971) 232-235
148. McCarthy D. Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology. Am J Med 105 (1998) 3S-9S
149. Bombardier C., Laine L., Reicin A., Shapiro D., Burgos-Vargas R., Davis B., et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343 (2000) 1520-1528 2 p following 1528
150. Bresalier R.S., Sandler R.S., Quan H., Bolognese J.A., Oxenius B., Horgan K., et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352 (2005) 1092-1102
151. Nussmeier N.A., Whelton A.A., Brown M.T., Langford R.M., Hoeft A., Parlow J.L., et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 352 (2005) 1081-1091
152. Solomon S.D., McMurray J.J., Pfeffer M.A., Wittes J., Fowler R., Finn P., et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352 (2005) 1071-1080
153. Cheng Y., Austin S.C., Rocca B., Koller B.H., Coffman T.M., Grosser T., et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296 (2002) 539-541
154. Qi Z., Hao C.M., Langenbach R.I., Breyer R.M., Redha R., Morrow J.D., et al. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 110 (2002) 61-69
155. Kobayashi T., Tahara Y., Matsumoto M., Iguchi M., Sano H., Murayama T., et al. Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest 114 (2004) 784-794
156. Blais V., Turrin N.P., and Rivest S. Cyclooxygenase 2 (COX-2) inhibition increases the inflammatory response in the brain during systemic immune stimuli. J Neurochem 95 (2005) 1563-1574
157. Kapoor M., Shaw O., and Appleton I. Possible anti-inflammatory role of COX-2-derived prostaglandins: implications for inflammation research. Curr Opin Investig Drugs 6 (2005) 461-466
158. Scher J.U., and Pillinger M.H. 15d-PGJ2: the anti-inflammatory
159. Mouihate A., Boisse L., and Pittman Q.J. A novel antipyretic action of 15-deoxy-Delta12,14-prostaglandin J2 in the rat brain. J Neurosci 24 (2004) 1312-1318
160. Tanioka T., Nakatani Y., Semmyo N., Murakami M., and Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 275 (2000) 32775-32782
161. Jakobsson P.J., Thoren S., Morgenstern R., and Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A 96 (1999) 7220-7225
162. Watanabe K., Kurihara K., and Suzuki T. Purification and characterization of membrane-bound prostaglandin E synthase from bovine heart. Biochim Biophys Acta 1439 (1999) 406-414
163. Ogino N., Miyamoto T., Yamamoto S., and Hayaishi O. Prostaglandin endoperoxide E isomerase from bovine vesicular gland microsomes, a glutathione-requiring enzyme. J Biol Chem 252 (1977) 890-895
164. Masuko-Hongo K., Berenbaum F., Humbert L., Salvat C., Goldring M.B., and Thirion S. Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways. Arthritis Rheum 50 (2004) 2829-2838
165. Giannico G., Mendez M., and LaPointe M.C. Regulation of the membrane-localized prostaglandin E synthases mPGES-1 and mPGES-2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol 288 (2005) H165-174
166. Degousee N., Angoulvant D., Fazel S., Stefanski E., Saha S., Iliescu K., et al. c-Jun N-terminal kinase-mediated stabilization of microsomal prostaglandin E2 synthase-1 mRNA regulates delayed microsomal prostaglandin E2 synthase-1 expression and prostaglandin E2 biosynthesis by cardiomyocytes. J Biol Chem 281 (2006) 16443-16452
167. de Oliveira A.C., Candelario-Jalil E., Bhatia H.S., Lieb K., Hull M., and Fiebich B.L. Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2. Glia 56 (2008) 844-855
168. Sampey A.V., Monrad S., and Crofford L.J. Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2. Arthritis Res Ther 7 (2005) 114-117
169. Naraba H., Yokoyama C., Tago N., Murakami M., Kudo I., Fueki M., et al. Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1. J Biol Chem 277 (2002) 28601-28608
170. Cheng S., Afif H., Martel-Pelletier J., Pelletier J.P., Li X., Farrajota K., et al. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. J Biol Chem 279 (2004) 22057-22065
171. Murakami M., Naraba H., Tanioka T., Semmyo N., Nakatani Y., Kojima F., et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275 (2000) 32783-32792
172. Thoren S., and Jakobsson P.J. Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4. Eur J Biochem 267 (2000) 6428-6434
173. Yamagata K., Matsumura K., Inoue W., Shiraki T., Suzuki K., Yasuda S., et al. Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J Neurosci 21 (2001) 2669-2677
174. Trebino C.E., Stock J.L., Gibbons C.P., Naiman B.M., Wachtmann T.S., Umland J.P., et al. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci U S A 100 (2003) 9044-9049
175. Uematsu S., Matsumoto M., Takeda K., and Akira S. Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J Immunol 168 (2002) 5811-5816
176. Kamei D., Yamakawa K., Takegoshi Y., Mikami-Nakanishi M., Nakatani Y., Oh-Ishi S., et al. Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1. J Biol Chem 279 (2004) 33684-33695
177. Trebino C.E., Eskra J.D., Wachtmann T.S., Perez J.R., Carty T.J., and Audoly L.P. Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages. J Biol Chem 280 (2005) 16579-16585
178. Inada M., Matsumoto C., Uematsu S., Akira S., and Miyaura C. Membrane-bound prostaglandin E synthase-1-mediated prostaglandin E2 production by osteoblast plays a critical role in lipopolysaccharide-induced bone loss associated with inflammation. J Immunol 177 (2006) 1879-1885
179. Kapoor M., Kojima F., Qian M., Yang L., and Crofford L.J. Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis. Faseb J 20 (2006) 2387-2389
180. Watanabe K., Kurihara K., Tokunaga Y., and Hayaishi O. Two types of microsomal prostaglandin E synthase: glutathione-dependent and -independent prostaglandin E synthases. Biochem Biophys Res Commun 235 (1997) 148-152
181. Tanikawa N., Ohmiya Y., Ohkubo H., Hashimoto K., Kangawa K., Kojima M., et al. Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun 291 (2002) 884-889
182. Murakami M., Nakashima K., Kamei D., Masuda S., Ishikawa Y., Ishii T., et al. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem 278 (2003) 37937-37947
183. Tanioka T., Nakatani Y., Kobayashi T., Tsujimoto M., Oh-ishi S., Murakami M., et al. Regulation of cytosolic prostaglandin E2 synthase by 90-kDa heat shock protein. Biochem Biophys Res Commun 303 (2003) 1018-1023
184. Kobayashi T., Nakatani Y., Tanioka T., Tsujimoto M., Nakajo S., Nakaya K., et al. Regulation of cytosolic prostaglandin E synthase by phosphorylation. Biochem J 381 (2004) 59-69
185. Engblom D., Ek M., Andersson I.M., Saha S., Dahlstrom M., Jakobsson P.J., et al. Induction of microsomal prostaglandin E synthase in the rat brain endothelium and parenchyma in adjuvant-induced arthritis. J Comp Neurol 452 (2002) 205-214
186. Dallaporta M., Pecchi E., Jacques C., Berenbaum F., Jean A., Thirion S., et al. c-Fos immunoreactivity induced by intraperitoneal LPS administration is reduced in the brain of mice lacking the microsomal prostaglandin E synthase-1 (mPGES-1). Brain Behav Immun 21 (2007) 1109-1121
187. Kapoor M., Kojima F., Qian M., Yang L., and Crofford L.J. Microsomal prostaglandin E synthase-1 deficiency is associated with elevated peroxisome proliferator-activated receptor gamma: regulation by prostaglandin E2 via the phosphatidylinositol 3-kinase and Akt pathway. J Biol Chem 282 (2007) 5356-5366
188. Saha S., Engstrom L., Mackerlova L., Jakobsson P.J., and Blomqvist A. Impaired febrile responses to immune challenge in mice deficient in microsomal prostaglandin E synthase-1. Am J Physiol Regul Integr Comp Physiol 288 (2005) R1100-1107
189. Xu D., Rowland S.E., Clark P., Giroux A., Cote B., Guiral S., et al. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation. J Pharmacol Exp Ther 326 (2008) 754-763
190. Pecchi E., Dallaporta M., Thirion S., Salvat C., Berenbaum F., Jean A., et al. Involvement of central microsomal prostaglandin E synthase-1 in IL-1beta-induced anorexia. Physiol Genomics 25 (2006) 485-492
191. Pecchi E., Dallaporta M., Jean A., Thirion S., and Troadec J.D. mPGES-1 knock-out mice are resistant to cancer-induced anorexia despite the absence of central mPGES-1 up-regulation in wild-type anorexic mice. J Neuroimmunol 199 (2008) 104-114
192. Elander L., Engstrom L., Hallbeck M., and Blomqvist A. IL-1beta and LPS induce anorexia by distinct mechanisms differentially dependent on microsomal prostaglandin E synthase-1. Am J Physiol Regul Integr Comp Physiol 292 (2007) R258-267
193. Samuelsson B., Morgenstern R., and Jakobsson P.J. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev 59 (2007) 207-224
194. Han R., Tsui S., and Smith T.J. Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression. J Biol Chem 277 (2002) 16355-16364
195. Kojima F., Naraba H., Sasaki Y., Okamoto R., Koshino T., and Kawai S. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells. J Rheumatol 29 (2002) 1836-1842
196. Premyslova M., Chisaka H., Okamura K., and Challis J.R. IL-1beta treatment does not co-ordinately up-regulate mPGES-1 and COX-2 mRNA expression, but results in higher degree of cellular and intracellular co-localization of their immunoreactive proteins in human placenta trophoblast cells. Placenta 27 (2006) 576-586